Overview
Bacteriostatic Water for Injection, USP is sterile, nonpyrogenic water containing benzyl alcohol, commonly 0.9% or 9 mg/mL, as a preservative. In peptide practice it is often used to reconstitute lyophilized vials for repeated small-volume withdrawals. Its formula is best understood as water plus preservative rather than a single molecule: H2O with 0.9% benzyl alcohol in the listed source description.
The preservative does not make a contaminated vial sterile. It suppresses microbial growth under defined conditions and supports multiple-dose container use when aseptic technique is maintained. The water itself provides the vehicle, while benzyl alcohol provides bacteriostatic activity. pH, tonicity, peptide stability, and compatibility remain separate issues.
Unlike most entries in this batch, bacteriostatic water is an FDA-regulated product when supplied as Bacteriostatic Water for Injection, USP. It is not meant for direct intravascular administration without an added solute and is not intended for neonates because benzyl alcohol exposure has been associated with serious toxicity in premature infants.
This guide covers what bacteriostatic water does, what it does not do, how peptide users should think about aseptic handling, and why sterility, beyond-use timing, and preservative compatibility matter more than simple reconstitution math.
Quick facts
- Mechanism
- Sterile aqueous diluent with benzyl alcohol preservative
- Primary use
- Peptide Reconstitution
- Evidence
- strong
- FDA
- Approved
- Route
- Diluent for parenteral products after drug addition
- Typical results
- Allows repeated vial withdrawals when used aseptically and within label limits
Chemical information
Bacteriostatic water is not a peptide and does not have one peptide-like molecular structure. It is sterile water, molecular mass 18.02 g/mol for H2O, containing benzyl alcohol preservative, commonly 0.9% or 9 mg/mL.
How Bacteriostatic Water works
Bacteriostatic water works as a vehicle. Water dissolves compatible lyophilized materials, while benzyl alcohol inhibits growth of some bacteria introduced during repeated withdrawals. The effect is preservative, not sterilizing. If a vial is contaminated, cloudy, mishandled, or outside dating, bacteriostatic water cannot rescue it.
The FDA label describes bacteriostatic water as a multiple-dose diluent for drugs that require dilution or dissolution before injection. Benzyl alcohol is included because repeated needle entry into a container increases contamination risk. Even so, aseptic technique remains essential: clean stoppers, sterile needles, proper storage, and discarding compromised vials are not optional.
Peptide compatibility is not guaranteed. Some peptides are unstable in water after reconstitution, some require specific pH or buffers, and some may be sensitive to benzyl alcohol. Bacteriostatic water is convenient for many research peptides, but it is not universally correct. The peptide's manufacturer, prescribing information, or validated formulation data should control the choice of diluent.
Safety concerns are mostly about misuse: neonate exposure to benzyl alcohol, direct injection of plain diluent, nonsterile compounding, repeated puncture beyond limits, and confusion between sterile water, bacteriostatic water, saline, and acidified solvents.
- Dilution vehicle: Provides sterile water for dissolving compatible drugs or peptides
- Benzyl alcohol: Adds bacteriostatic preservative activity for multi-dose use
- Not sterilizing: Suppresses growth but does not neutralize gross contamination
- Multiple-dose use: Designed for repeated withdrawals under aseptic technique
- Compatibility dependent: Some peptides or biologics may require different diluents
- Neonate warning: Benzyl alcohol-containing products are not intended for newborns
Pharmacokinetics
The pharmacokinetics of bacteriostatic water as a standalone product are not the point of use. Safety depends on the added drug, final formulation, route, volume, and benzyl alcohol exposure.
| Parameter | Value | Significance |
|---|---|---|
| Active drug | None | Acts as a diluent rather than a therapeutic agent |
| Preservative | Benzyl alcohol 0.9% typical | Suppresses microbial growth in multi-dose containers |
| Use container | Multiple-dose vial | Repeated withdrawals require aseptic technique |
| pH | Label range around 4.5-7.0 | May affect peptide compatibility |
| Neonate use | Contraindicated/not intended | Benzyl alcohol exposure has caused serious toxicity |
| Storage after puncture | Follow product and facility policy | Preservative does not remove beyond-use limits |
Dosing & administration
Bacteriostatic water does not have a therapeutic dose. The relevant calculation is reconstitution volume, which determines final drug concentration. That calculation must be based on the peptide mass in the vial and the intended measured dose, but the diluent itself is not the active ingredient.
Aseptic handling is the main practical skill. Use a sterile syringe and needle, disinfect the stopper, avoid touching sterile parts, inject diluent slowly along the vial wall when appropriate, and do not use cloudy, discolored, or particle-containing solutions. Refrigeration requirements depend on the reconstituted peptide, not just the water.
If a drug label specifies sterile water, saline, acidic diluent, or a manufacturer-supplied solvent, bacteriostatic water should not be substituted casually. Benzyl alcohol can be incompatible with certain biologics and is inappropriate for newborns.
Side effects & safety
Bacteriostatic water is safe when used as labeled, with compatible drugs and aseptic technique. It becomes risky when used as a stand-alone injection, substituted for required diluents, used in neonates, or handled as if preservative equals sterility.
Common
- • Injection site burning if final solution is irritating
- • Local redness from the drug or diluent combination
- • Mild hypersensitivity to benzyl alcohol
- • Peptide precipitation if incompatible
- • Loss of potency after prolonged storage
- • Stinging from improper final concentration or pH
Serious / potential risks
- • Benzyl alcohol toxicity in neonates
- • Infection from poor aseptic technique
- • Pyrogenic reaction from contaminated preparation
- • Tissue injury from inappropriate final formulation
- • Medication error from using the wrong diluent
Drug interactions
Interactions are compatibility issues with the reconstituted drug rather than pharmacologic interactions from the water itself.
| Medication | Interaction | Recommendation |
|---|---|---|
| Neonatal medications | Benzyl alcohol exposure can be dangerous in newborns | Avoid benzyl alcohol-containing diluents in neonates |
| Biologics sensitive to preservatives | Benzyl alcohol may affect stability or tolerability | Follow product-specific instructions |
| Peptides requiring acidic solvent | May not dissolve or may precipitate | Use validated reconstitution guidance |
| Large-volume injections | Plain water is hypotonic before drug addition | Do not inject large volumes without proper formulation |
| Multi-dose compounded products | Repeated puncture increases contamination risk | Use aseptic technique and discard by policy |
Storage & handling
Lyophilized (powder)
- • Store at -20°C to 4°C (freezer or refrigerator)
- • Protect from light and moisture
- • Stable for 12–24 months when stored properly
- • Keep in original sealed container until reconstitution
Reconstituted solution
- • Refrigerate at 2–8°C after reconstitution
- • Use bacteriostatic water for multi-dose reconstitution
- • Typical stability: 14–28 days refrigerated
- • Do not freeze reconstituted solution
Cost & availability
| Source | Cost | Notes |
|---|---|---|
| Retail pharmacy | $5-$25 per 30 mL vial | Availability varies and may require prescription or pharmacy access |
| Medical supply distributors | $3-$15 per vial in quantity | Regulated supply chain is preferable |
| Research suppliers | $10-$40 per vial | Verify sterility and product labeling |
The bottom line
Bacteriostatic water is the practical workhorse diluent for many injectable peptide preparations, but it is not magic. It must be sterile, compatible, handled aseptically, and used within appropriate limits. Benzyl alcohol helps suppress growth; it does not fix contamination or validate unsafe compounding.
Best for
- • Reconstituting compatible lyophilized peptides
- • Multiple small withdrawals under aseptic technique
- • Clinically labeled multi-dose dilution workflows
Not for
- • Neonates or benzyl alcohol-sensitive settings
- • Direct injection without an added drug or proper formulation
- • Peptides requiring a different pH or solvent
- • Extending vial life beyond safe-use policies
Related compounds
Acetic Acid
Related entry from the same enrichment batch for comparison of evidence, handling, and user-safety context.
Amino Tadalafil
Related entry from the same enrichment batch for comparison of evidence, handling, and user-safety context.
AOD-9604
Related entry from the same enrichment batch for comparison of evidence, handling, and user-safety context.
Astressin-B
Related entry from the same enrichment batch for comparison of evidence, handling, and user-safety context.
Frequently asked questions
References
- [1] Hospira, Inc.. Bacteriostatic Water for Injection, USP prescribing information. DailyMed (2024).
- [2] U.S. Food and Drug Administration. Bacteriostatic Water for Injection label and NDA information. FDA Drug Label (2024).
- [3] Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. New England Journal of Medicine (1982). PMID: 7050706
- [4] American Society of Health-System Pharmacists. ASHP guidelines on compounding sterile preparations. American Journal of Health-System Pharmacy (2014). PMID: 25027502
- [5] United States Pharmacopeia. General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. USP (2023).
- [6] National Center for Biotechnology Information. PubChem Compound Summary for Benzyl Alcohol. PubChem (2026).